CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030

Starting Price : $ 4000.00 $3200.00 | Pages : 243 | Published : November 2020 | SKU CODE : 7601 | Format :

Request Sample

CAR-T Therapy Market Definition

The chimeric antigen receptor -T therapy market consists of sales of CAR-T therapy products and related services by entities (organizations, sole traders and partnerships) that develop chimeric antigen receptor (CAR) T-cell therapies to treat blood cancers.

CAR-T therapy is type of immunotherapy in which T-cells taken from patient’s blood are modified in a laboratory with the addition of a special protein receptor that grants T-cells the power to recognize as well as kill cancer cells easily, along with infusing the same back into that patient. This special protein receptor, known as chimeric antigen receptor (CAR), attaches to a specific protein on a patient’s cancer cells. The infused cells multiply and prevail in the patient’s body as living drugs.

CAR-T Therapy Market Size

The global CAR-T therapy market reached a value of nearly $734.0 million in 2019.  The market is expected to grow from $734.0 million in 2019 to $ 2,250 million in 2023 at a rate of 32.3%. The growth is mainly due to an increased prevalence of cancer and increased awareness about the therapy. The market is expected to stabilize and reach $3,150 million in 2025 and $ 6,100 million in 2030.

Growth in the historic period resulted from increases in healthcare expenditure, increase in pharmaceutical R&D expenditure and advances in drug discovery. This growth was restricted by low rate of drug approvals, challenges due to regulatory changes and limited number of treatment centers.

Going forward, increase in blood cancer incidence rate, rise in healthcare expenditure, strong pipeline of drugs and rising focus on car-t therapy are expected to drive the market. High costs of therapy, reimbursement challenges, adverse events, complex manufacturing and supply chain and covid-19 impacting drug trails, and reduction in free trade are major factors that could hinder the growth of the CAR-T therapy market in the future.

CAR-T Therapy Market Drivers

The key drivers of the CAR-T therapy market during 2019–2023 included:

Increase in Blood Cancer Incidence Rate

The rise in the number of blood cancer cases across the globe is likely to contribute to the growth of the CAR-T therapy market during the forecast period. According to the American Cancer Society, there were 17,62,450 new cases and 606,880 cancer deaths in 2019 in the USA. New cases of leukemia, lymphoma and myeloma are expected to account for 9.9% of the estimated 1,806,590 new cancer cases diagnosed in the US in 2020 and in approximately every 3 minutes one person in the US is diagnosed with a blood cancer. Therefore, the rise in the blood cancer incidence rate globally is anticipated to boost the demand for the CAR-T therapy market over the forthcoming years.

CAR-T Therapy Market Restraints

The key restraints on the CAR-T therapy market during 2019–2023 included:

High Costs Of Therapy

High costs associated with the CAR-T therapy is a major issue faced by citizens of many countries. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective therapies for cancer has influenced the health conditions of the population and has led to a low average life expectancy. According to a 2019 study, factoring in all the costs associated with CAR T-cell therapy, hospitals may charge as much as $1.5 million to avoid losing money, thus restraining the growth of the market.

CAR-T Therapy Market Trends

Major trends shaping the CAR-T therapy market include the following –

Remodeled CAR-T Cell Therapy for Fewer Side Effects

The developers and providers of the CAR-T therapy market are investing in research and development to remodel the design of CAR-T therapy to reduce its side effects on cancer patients. The original CAR-T therapy causes neurologic side effects such as delirium, speech problems, seizures and tremors though it provides long-lasting remissions for some patients with very advanced cancer. The remodeled CAR-T therapy with a renewed design results in far fewer neurologic side effects than that of the original therapy. It also helps to reduce the levels of cytokines which cause neurologic side effects. For instance, in February 2020, the National Cancer Institute in the United States modified the design of the original CAR-T therapy and conducted it on 20 patients as trial. The results showed that only one patient out of the 20 in the trial had severe neurologic side effects. The new CAR-T therapy also resulted in the slow growth of tumors and minimized the levels of cytokines.

Off-The-Shelf Allogeneic CAR-T Therapy for Improved Treatment

Companies in the CAR-T therapy market are focusing on developing off-the-shelf allogeneic CAR-T therapy for new and improved cancer treatment. The use of the first type of allogeneic CAR-T therapy has many benefits including decreased cost using an industrialized process, time for multiple cell modifications, immediate availability of cryopreserved batches for patient treatment, redosing or combination of CAR-T cells directed against different targets and possible standardization of the CAR-T cell product. However, this therapy may cause life-threatening graft-versus-host disease and may quickly destroy the allogeneic CAR-T cells by the host immune system. The new-generation allogeneic CAR-T therapy helps to overcome these challenges. For instance, in November 2019, Precision BioSciences, Inc., a biotechnology company created a new generation allogeneic CAR-T therapy and is conducting an ongoing?trial of this therapy by creating its first off-the-shelf allogeneic CAR-T therapy candidate known as PBCAR0191. This is?in collaboration with Servier, an international pharmaceutical company and is mainly for the patients in need of advanced cancer treatment options

Opportunities And Recommendations In The CAR-T Therapy Market

Opportunities – The top opportunities in the CAR-T therapy market segmented by target antigen will arise in the CD19 segment, which will gain $1,077.3 million of global annual sales by 2023. The top opportunities in the CAR-T therapy market segmented by application will arise in the diffuse large B-cell lymphoma segment, which will gain $738.5 million of global annual sales by 2023. The CAR-T therapy market size will gain the most in the USA at $744.9 million.

Recommendations- To take advantage of the opportunities, the business research company recommends the CAR-T therapy companies should consider collaborating or acquiring competitor companies, invest in machine learning and artificial intelligence, next-generation car-t cells, competitive pricing, expanding in emerging markets, set up authorized distributors and sales representatives, leverage e-commerce to maximize reach and revenues, increasing adoption of internet, attending business events, targeting community oncologists/hematologists, and collaboration with treatment centers.

CAR-T Therapy Market Segmentation

The CAR-T therapy market is segmented by type of target, by application
By Target Antigen- The CAR-T therapy market is segmented by target antigen into
    • a. CD19 Therapy
    • b. CD22 Therapy
    • c. BCMA Therapy
    • d. Others
The CD19 was the largest segment of the CAR-T therapy market by target antigen, accounting for 100% of the total market in 2019. Going forward, CD19 segment is expected to be the fastest growing segment in the CAR-T therapy market, at a CAGR of 25.3%.
By Application- The CAR-T therapy market is also segmented by application into
    • a. Acute Lymphoblastic Leukemia
    • b. Diffuse Large B-Cell Lymphoma
    • c. Follicular Lymphoma
    • d. Chronic Lymphocytic Leukemia
    • e. Multiple Myeloma
    • f. Others
The diffuse large B-cell lymphoma was the largest segment of the CAR-T therapy market by application, accounting for 56.1% of the total market in 2019. Going forward, the others segment is expected to be the fastest growing segment in the CAR-T therapy market, at a CAGR of 29.3%.
By Geography- The CAR-T therapy market is segmented into
    • o North America
      • USA
    • o Western Europe
      • France
      • Germany
      • UK
    • o Asia Pacific
      • China
      • India
      • Indonesia
      • Japan
      • South Korea
      • Australia
    • o Eastern Europe
      • Russia
    • o South America
      • Brazil
    • o Middle East
    • o Africa
North America was the largest region in the global CAR-T therapy market, accounting for 60.3% of the total in 2019. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the CAR-T therapy market will be Asia Pacific and Western Europe, where growth will be at CAGRs of 85.1% and 32.4% respectively.

CAR-T Therapy Competitive Landscape

Major Competitors are:
    • • Gilead Sciences
    • • Novartis AG
Other Competitors Include:
    • • Gracell Biotechnology Ltd
    • • Aeon Therapeutics
    • • CARsgen Therapeutics
    • • Daiichi Sankyo
    • • Celegne
    • • Otsuka Pharmaceutical
    • • Biocon
    • • Ono Pharmaceutical
    • • Japan Tissue Engineering
    • • Nipro Corporation
    • • Takeda Pharmaceutical Company
    • • Astellas Pharma
    • • Innovative Cellular Therapeutics Cellular Biomedicine Group
    • • PersonGen Biomedicine
    • • Hebei Senlang Biotech
    • • Eli Lilly and Company
    • • Johnson & Johnson Private Limited
    • • MSD Laboratories India LLC
    • • AstraZeneca Holding GmbH
    • • Astellas Pharma
    • • Adaptimmune
    • • Autolus Therapeutics
    • • BioNTech
    • • Cellectis
    • • Celyad
    • • Crescendo Biologics
    • • GammaDelta Therapeutics
    • • Immatics

    "1. CAR-T Therapy Market Executive Summary

    2. Table of Contents

    3. List of Figures

    4. List of Tables

    5. Report Structure

    6. Introduction

    6.1.1. Segmentation By Geography

    6.1.2. Segmentation By Application

    6.1.3. Segmentation By Target Antigen

    7. CAR-T Therapy Market Characteristics

    7.1. Market Definition

    7.2. Market Segmentation By Target Antigen

    7.2.1. CD19 Therapy

    7.2.2. CD22 Therapy

    7.2.3. BCMA Therapy

    7.2.4. Others

    7.3. Market Segmentation By Application

    7.3.1. Acute Lymphoblastic Leukemia

    7.3.2. Diffuse Large B-Cell Lymphoma

    7.3.3. Follicular Lymphoma

    7.3.4. Chronic Lymphocytic Leukemia

    7.3.5. Multiple Myeloma

    7.3.6. Others

    8. CAR-T Therapy Market Customer Information

    8.1. Interest Of Physicians

    8.2. Positive Perception Of Community Oncologists Towards CAR-T Therapy

    8.3. Challenges And Perceived Barriers In The Adoption Of CAR-T Therapy by Community Oncologists

    8.4. Improvement In Quality Of Life After CAR T-Cell Therapy

    9. CAR-T Therapy Market Trends And Strategies

    9.1. Remodeled CAR-T Cell Therapy For Fewer Side Effects

    9.2. Off-The-Shelf Allogeneic CAR-T Therapy For Improved Treatment

    9.3. Next-Generation CAR-T Cells For Treatment Of High-Grade Glioma

    9.4. Machine Learning And Artificial Intelligence To Optimize Future CAR-T Therapy

    9.5. Collaborating With Technology Companies For Advanced Technologies

    9.6. Growing Partnerships For Promoting CAR-T Therapy Market

    10. CAR-T Therapy Market, COVID Impact Analysis

    10.1. Impact On Global CAR-T Therapy

    10.2. Impact On Global CAR-T Therapy Clinical Trials

    10.3. Impact On Leading Global Oncology Companies

    11. Global CAR-T Therapy Market Size And Growth

    11.1. Historic Market Growth, 2015 – 2019, Value ($ Million)

    11.1.1. Drivers Of The Market 2015 – 2019

    11.1.2. Restraints On The Market 2015 – 2019

    11.2. Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    11.2.1. Drivers Of The Market 2019 – 2023

    11.2.2. Restraints On The Market 2019 – 2023

    12. Global CAR-T Therapy Market Segmentation

    12.1. Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    12.1.1. Diffuse Large B-Cell Lymphoma

    12.1.2. Acute Lymphoblastic Leukemia

    12.1.3. Follicular Lymphoma

    12.1.4. Multiple Myeloma

    12.1.5. Chronic Lymphocytic Leukemia

    12.1.6. Others

    12.2. Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    12.2.1. CD19

    12.2.2. BCMA

    12.2.3. Other Target Antigen

    12.2.4. CD22

    13. CAR-T Therapy Market, Regional And Country Analysis

    13.1. Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    13.2. Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    14. Asia-Pacific CAR-T Therapy Market

    14.1. Asia-Pacific CAR-T Therapy Market Overview

    14.1.1. Region Information

    14.1.2. Market Information

    14.1.3. Impact of COVID-19

    14.1.4. Background Information

    14.1.5. Government Initiatives

    14.1.6. Regulations

    14.1.7. Regulatory Bodies

    14.1.8. Major Associations

    14.1.9. Taxes Levied

    14.1.10. Corporate Tax Structure

    14.1.11. Investment

    14.1.12. Major Companies

    14.2. Asia-Pacific CAR-T Therapy Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    14.3. Asia-Pacific CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    14.4. Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    14.5. Asia-Pacific CAR-T Therapy Market: Country Analysis

    14.6. China CAR-T Therapy Market

    14.7. China CAR-T Therapy Market Overview

    14.7.1. Country Information

    14.7.2. Market Information

    14.7.3. Impact of COVID-19

    14.7.4. Background Information

    14.7.5. Government Initiatives

    14.7.6. Regulations

    14.7.7. Regulatory Bodies

    14.7.8. Major Associations

    14.7.9. Taxes Levied

    14.7.10. Corporate Tax Structure

    14.7.11. Investment

    14.7.12. Major Companies

    14.8. China CAR-T Therapy Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    14.9. China CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    14.10. China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    14.11. India CAR-T Therapy Market

    14.12. India CAR-T Therapy Market Overview

    14.12.1. Country Information

    14.12.2. Market Information

    14.12.3. Impact of COVID-19

    14.12.4. Background Information

    14.12.5. Government Initiatives

    14.12.6. Regulations

    14.12.7. Regulatory Bodies

    14.12.8. Major Associations

    14.12.9. Taxes Levied

    14.12.10. Corporate Tax Structure

    14.12.11. Investment

    14.12.12. Major Companies

    14.13. India CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    14.14. India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    14.15. Japan CAR-T Therapy Market

    14.16. Japan CAR-T Therapy Market Overview

    14.16.1. Country Information

    14.16.2. Market Information

    14.16.3. COVID-19 Impact

    14.16.4. Background Information

    14.16.5. Government Initiatives

    14.16.6. Regulations

    14.16.7. Regulatory Bodies

    14.16.8. Major Associations

    14.16.9. Taxes Levied

    14.16.10. Corporate Tax Structure

    14.16.11. Investment

    14.16.12. Major Companies

    14.17. Japan CAR-T Therapy Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    14.18. Japan CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    14.19. Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    14.20. Australia CAR-T Therapy Market

    14.21. Australia CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    14.22. Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    14.23. Indonesia CAR-T Therapy Market

    14.24. Indonesia CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    14.25. Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    14.26. South Korea CAR-T Therapy Market

    14.27. South Korea CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    14.28. South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    15. Western Europe CAR-T Therapy Market

    15.1. Western Europe CAR-T Therapy Market Overview

    15.1.1. Region Information

    15.1.2. Market Information

    15.1.3. Impact of COVID-19

    15.1.4. Background Information

    15.1.5. Government Initiatives

    15.1.6. Regulations

    15.1.7. Regulatory Bodies

    15.1.8. Major Associations

    15.1.9. Taxes Levied

    15.1.10. Corporate Tax Structure

    15.1.11. Investments

    15.1.12. Major Companies

    15.2. Western Europe CAR-T Therapy Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    15.3. Western Europe CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    15.4. Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    15.5. Western Europe CAR-T Therapy Market: Country Analysis

    15.6. UK CAR-T Therapy Market

    15.7. UK CAR-T Therapy Market Overview

    15.7.1. Country Information

    15.7.2. Market Information

    15.7.3. Impact of COVID-19

    15.7.4. Background Information

    15.7.5. Government Initiatives

    15.7.6. Regulations

    15.7.7. Regulatory Bodies

    15.7.8. Associations

    15.7.9. Taxes Levied

    15.7.10. Corporate Tax Structure

    15.7.11. Major Companies

    15.8. UK CAR-T Therapy Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    15.9. UK CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    15.10. UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    15.11. Germany CAR-T Therapy Market

    15.12. Germany CAR-T Therapy Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    15.13. Germany CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    15.14. Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    15.15. France CAR-T Therapy Market

    15.16. France CAR-T Therapy Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    15.17. France CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    15.18. France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    16. Eastern Europe CAR-T Therapy Market

    16.1. Eastern Europe CAR-T Therapy Market Overview

    16.1.1. Region Information

    16.1.2. Market Information

    16.1.3. Impact of COVID-19

    16.1.4. Background Information

    16.1.5. Government Initiatives

    16.1.6. Regulations

    16.1.7. Regulatory Bodies

    16.1.8. Associations

    16.1.9. Taxes Levied

    16.1.10. Corporate Tax Structure

    16.1.11. Investments

    16.1.12. Major Companies

    16.2. Eastern Europe CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    16.3. Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    16.4. Eastern Europe CAR-T Therapy Market: Country Analysis

    16.5. Russia CAR-T Therapy Market

    16.6. Russia CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    16.7. Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    17. North America CAR-T Therapy Market

    17.1. North America CAR-T Therapy Market Overview

    17.1.1. Region Information

    17.1.2. Impact Of COVID-19

    17.1.3. Market Information

    17.1.4. Background Information

    17.1.5. Government Initiatives

    17.1.6. Regulations

    17.1.7. Regulatory Bodies

    17.1.8. Major Associations

    17.1.9. Taxes Levied

    17.1.10. Corporate Tax Structure

    17.1.11. Investments

    17.1.12. Major Companies

    17.2. North America CAR-T Therapy Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    17.3. North America CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    17.4. North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    17.5. North America CAR-T Therapy Market: Country Analysis

    17.6. USA CAR-T Therapy Market

    17.7. USA CAR-T Therapy Market Overview

    17.7.1. Country Information

    17.7.2. Impact Of COVID-19

    17.7.3. Market Information

    17.7.4. Background Information

    17.7.5. Government Initiatives

    17.7.6. Regulations

    17.7.7. Regulatory Bodies

    17.7.8. Major Associations

    17.7.9. Corporate Tax Structure

    17.7.10. Investments

    17.7.11. Major Companies

    17.8. USA CAR-T Therapy Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    17.9. USA CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    17.10. USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    18. South America CAR-T Therapy Market

    18.1. South America CAR-T Therapy Market Overview

    18.1.1. Region Information

    18.1.2. COVID Impact

    18.1.3. Market Information

    18.1.4. Background Information

    18.1.5. Government Initiatives

    18.1.6. Regulations

    18.1.7. Regulatory Bodies

    18.1.8. Major Associations

    18.1.9. Taxes Levied

    18.1.10. Corporate Tax Structure

    18.1.11. Major Companies

    18.2. South America CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18.3. South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    18.4. South America CAR-T Therapy Market: Country Analysis

    18.5. Brazil CAR-T Therapy Market

    18.6. Brazil CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18.7. Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    19. Middle East CAR-T Therapy Market

    19.1. Middle East CAR-T Therapy Market Overview

    19.1.1. Region Information

    19.1.2. Market Information

    19.1.3. Impact of COVID-19

    19.1.4. Background Information

    19.1.5. Government Initiatives

    19.1.6. Regulations

    19.1.7. Regulatory Bodies

    19.1.8. Major Associations

    19.1.9. Investments

    19.1.10. Taxes Levied

    19.1.11. Corporate Tax Structure

    19.1.12. Major Companies

    19.2. Middle East CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    19.3. Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    20. Africa CAR-T Therapy Market

    20.1. Africa CAR-T Therapy Market Overview

    20.1.1. Region Information

    20.1.2. Market Information

    20.1.3. Impact Of COVID-19

    20.1.4. Background Information

    20.1.5. Government Initiatives

    20.1.6. Regulations

    20.1.7. Regulatory Bodies

    20.1.8. Major Associations

    20.1.9. Taxes Levied

    20.1.10. Corporate Tax Structure

    20.1.11. Major Companies

    20.2. Africa CAR-T Therapy Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    20.3. Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    21. Global CAR-T Therapy Market Competitive Landscape

    21.1. Company Profiles

    21.2. Gilead Sciences

    21.2.1. Company Overview

    21.2.2. Products And Services

    21.2.3. Business Strategy

    21.2.4. Financial Overview

    21.3. Novartis AG

    21.3.1. Company Overview

    21.3.2. Products And Services

    21.3.3. Business Strategy

    21.3.4. Financial Overview

    22. CAR-T Therapy Pipeline Analysis

    22.1. Comparison Of The Landscape Of Active Trials Of Cancer Cell Therapies In 2020

    22.2. CAR T-Cell Therapy, Number Of Active Trials By Cancer Type

    22.3. CAR T-Cell Therapy, Number Of Active Trials By Cancer Type

    22.4. Global CAR-T Cell Therapy By Trial Site

    22.5. Number of Molecules In Cancer Clinical Trails, By Target

    22.6. CAR-T Cell Therapy Pipeline Analysis

    23. Key Mergers And Acquisitions In The CAR-T Therapy Market

    23.1. ResTORbio Merged With Adicet Bio

    23.2. Astellas Pharma Acquired Xyphos Biosciences

    23.3. Bristol Myers Squibb Acquired Celgene Corporation

    23.4. Celgene Acquired Juno Therapeutics

    23.5. Gilead Sciences Acquired Cell Design Labs

    23.6. Gilead Sciences Acquired Kite Pharma

    24. CAR-T Therapy Market Opportunities And Strategies

    24.1. Global CAR-T Therapy Market In 2023 – Countries Offering Most New Opportunities

    24.2. Global CAR-T Therapy Market In 2023 – Segments Offering Most New Opportunities

    24.3. Global CAR-T Therapy Market In 2023 – Growth Strategies

    24.3.1. Market Trend Based Strategies

    24.3.2. Competitor Strategies

    25. CAR-T Therapy Market, Conclusions And Recommendations

    25.1. Conclusions

    25.2. Recommendations

    25.2.1. Product

    25.2.2. Price

    25.2.3. Place

    25.2.4. Promotion

    25.2.5. People

    26. Appendix

    26.1. Market Data Sources

    26.2. Research Methodology

    26.3. Currencies

    26.4. Research Inquiries

    26.5. The Business Research Company

    26.6. Copyright and Disclaimer

List Of Tables

    "Table 1: Global CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Table 2: Global CAR-T Therapy Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 3: Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 4: Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 5: Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 6: Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 7: Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 8: Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 9: Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 10: Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 11: Asia-Pacific Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 12:  Asia Pacific Population By Age Group, 2015-2023, Thousands
  • Table 13: Asia-Pacific Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 14:  Asia Pacific Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 15: Asia-Pacific CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Table 16: Asia-Pacific CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 17: Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 18: Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 19: China Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 20:  China Population By Age Group, 2015-2023, Thousands
  • Table 21: China Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 22:  China Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 23: China CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Table 24: China CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 25: China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 26: China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 27: India Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 28:  India Population By Age Group, 2015-2023, Thousands
  • Table 29: India Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 30:  India Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 31: India CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 32: India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 33: India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 34: Japan Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 35:  Japan Population By Age Group, 2015-2023, Thousands
  • Table 36: Japan Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 37:  Japan Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 38: Japan CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Table 39: Japan CAR-T Therapy Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 40: Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 41: Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 42: Australia CAR-T Therapy Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 43: Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 44: Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 45: Indonesia CAR-T Therapy Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 46: Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 47: Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 48: South Korea CAR-T Therapy Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 49: South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 50: South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 51: Western Europe Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 52:  Western Europe Population By Age Group, 2015-2023, Thousands
  • Table 53: Western Europe Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 54:  Western Europe Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 55: Corporate Tax Structure In Western Europe Countries, %
  • Table 56: Western Europe CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Table 57: Western Europe CAR-T Therapy Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 58: Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 59: Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 60: UK Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 61:  UK Population By Age Group, 2015-2023, Thousands
  • Table 62: UK Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 63:  UK Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 64: UK CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Table 65: UK CAR-T Therapy Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 66: UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 67: UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 68: Germany CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Table 69: Germany CAR-T Therapy Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 70: Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 71: Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 72: France CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Table 73: France CAR-T Therapy Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 74: France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 75: France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 76: Eastern Europe Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 77:  Eastern Europe Population By Age Group, 2015-2023, Thousands
  • Table 78: Eastern Europe Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 79:  Eastern Europe Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 80: Eastern Europe CAR-T Therapy Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 81: Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 82: Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 83: Russia CAR-T Therapy Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 84: Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 85: Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 86: North America Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 87:  North America Population By Age Group, 2015-2023, Thousands
  • Table 88: North America Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 89:  North America Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 90: North America CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Table 91: North America CAR-T Therapy Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 92: North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 93: USA Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 94:  USA Population By Age Group, 2015-2023, Thousands
  • Table 95: USA Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 96:  USA Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 97: USA CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Table 98: USA CAR-T Therapy Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 99: USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 100: South America Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 101:  South America Population By Age Group, 2015-2023, Thousands
  • Table 102: South America Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 103:  South America Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 104: South America CAR-T Therapy Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 105: South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 106: South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 107: Brazil CAR-T Therapy Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 108: Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 109: Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 110: Middle East Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 111:  Middle East Population By Age Group, 2015-2023, Thousands
  • Table 112: Middle East Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 113:  Middle East Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 114: Middle East CAR-T Therapy Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 115: Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 116: Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 117: Africa Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 118:  Africa Population By Age Group, 2015-2023, Thousands
  • Table 119: Africa Blood Cancer Drugs Market Size, 2015-2019, $ Billion
  • Table 120:  Africa Five-Year Prevalence Of Blood Related Cancers, 2015-2019
  • Table 121: Africa CAR-T Therapy Market, Forecast, 2019 – 2023,  2025F, 2030F, $ Million
  • Table 122: Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 123: Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 124: Global CAR-T Therapy Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Table 125: Gilead Sciences – Financial Performance, 2015 – 2019, $ Billion
  • Table 126: Novartis AG – Financial Performance, 2015 – 2019, $ Billion
  • Table 127:  Pipeline Analysis Of CAR-T Cell Therapy
  • Table 128: Global CAR-T Therapy Market Size Gain ($ Million), 2019 – 2023, By Country
  • Table 129: Global CAR-T Therapy Market Size Gain ($ Million), Segmentation By Application, 2019 – 2023
  • Table 130: Global CAR-T Therapy Market Size Gain ($ Million), Segmentation By Target Antigen, 2019 – 2023
  • Table 131: CAR-T Therapy Market Data Sources

List Of Figures

    "Figure 1: Global CAR-T Therapy Market Segmentation By Application
  • Figure 2: Global CAR-T Therapy Market Segmentation By Target Antigen
  • Figure 3: Global CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Figure 4: Global CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 5: Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 6: Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 7: Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 8: Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 9: Asia-Pacific CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Figure 10: Asia-Pacific CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 11: Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 12: China CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Figure 13: China CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 14: China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 15: India CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 16: India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 17: Japan CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Figure 18: Japan CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 19: Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 20: Australia CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 21: Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 22: Indonesia CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 23: Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 24: South Korea CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 25: South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 26: Western Europe CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Figure 27: Western Europe CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 28: Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 29: UK CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Figure 30: UK CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 31: UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 32: Germany CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Figure 33: Germany CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 34: Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 35: France CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Figure 36: France CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 37: France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 38: Eastern Europe CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 39: Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 40: Russia CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 41: Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 42: North America CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Figure 43: North America CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 44: North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 45: USA CAR-T Therapy Market, Historic, 2015 – 2019, $ Million
  • Figure 46: USA CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 47: USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 48: South America CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 49: South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 50: Brazil CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 51: Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 52: Middle East CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 53: Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 54: Africa CAR-T Therapy Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 55: Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 56: Global CAR-T Therapy Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Figure 57: Gilead Sciences – Financial Performance, 2015 – 2019, $ Billion
  • Figure 58: Novartis AG – Financial Performance, 2015 – 2019, $ Billion
  • Figure 59: CAR-T Therapy Market, Comparison Of The Landscape Of Active Trials Of Cancer Cell Therapies In 2020
  • Figure 60: CAR-T Therapy Market, Number Of Active Trials By Cancer Type
  • Figure 61: CAR-T Therapy Market, Number Of Active Trials By Cancer Type
  • Figure 62: CAR-T Therapy Market, Global CAR-T Cell Therapy By Trial Site
  • Figure 63: CAR-T Therapy Market, Number of Molecules In Cancer Clinical Trials, By Target
New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)